JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration. NEXT EVENTS:
Thursday 7th May 2020ICH Q3E (Extractables and Leachables): setting the sceneRoyal Society of Chemistry, London
ICH Q3E (Extractables and Leachables) has been adopted by the ICH governing body as ICH Q3E and will now progress through the various ICH stages that will culminate as an international harmonised guideline. This meeting will be an important event in understanding and trying to influence the outcome of the ICH Q3E proceedings.DETAILS AND REGISTRATION
Thursday 3rd December 2020Data integrity IIRoyal Society of Chemistry, London LAST EVENT:
Data integrity still continues to be a very hot topic for Industry and regulators alike. Data integrity still appears in the list of top five audit findings. This is a must attend meeting for anyone involved in addressing issues and challenges associated with data integrity.DETAILS AND REGISTRATION
Thursday 6th February 2020In silico techniquesRoyal Society of Chemistry, London
As the pace of pharmaceutical development accelerates, and organisations look to reduce timelines in all parts of the discovery and development process, opportunities emerge for the greater use of in silico tools to reduce the demand for materials or experimental tests. This meeting will showcase a range of applications of in silico modelling, whether for prediction of properties via first principles modelling, or applying contemporary tools for data-driven modelling. Examples covering chromatography and the physical form of drugs will be discussed, as well as tools for prediction of the key performance properties such as toxicology, dissolution and stability.DETAILS
In line with the latest government advice on social distancing, JPAG has had to take a decision about its future programme of events. Therefore the symposia scheduled for May and July will not take place as conventional meetings.
JPAG is working hard to offer these events in alternative formats and so please watch for updates in the near future. We will continue to accept registrations for the events.
If the events are cancelled without the option of an alternative format and you have paid a registration fee then this will be refunded. Please note the Terms and Conditions (which are on the JPAG website) concerning travel expenses.
Thank you for your understanding at this difficult time.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical ReviewTESTIMONIALS:Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
JPAG members can receive a free hard copy subscription to EPRclick here
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
The role of ELSIE in evolving current thinking on extractables and lea
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "The role of ELSIE in evolving current thinking on extractables and leachables" written by Dr Dave Elder, Past-Chairman of the JP...More...Wednesday 19th February 2020
ICH M9: biopharmaceutics classification system-based biowaivers
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH Q12: "ICH M9: biopharmaceutics classification system-based biowaivers" written by Dr Dave Elder, Past-Chairman of the JPAG C...More...Monday 6th January 2020
ICH Q12: Technical and regulatory considerations for pharmaceutical pr
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH Q12: Technical and regulatory considerations for pharmaceutical product lifecycle management" written by Dr Dave Elder, Past...More...Monday 6th January 2020
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).